женская онкология

The data of the first intermediate analysis of results of research BCRIG01 are published, in which comparison of efficiency of standard mode FAC (500/50/500) with a таксан-containing mode (with inclusion Таксотера) ТАС (75/50/500 (1) is lead{carried out}. Both modes were used with an interval of 3 weeks in quantity{amount} of 6 rates. This first published research estimating a role доцетаксела (Таксотера) in адъювантной of therapy of a cancer dairy железы. Earlier in two other researches (С9344 and В30) the role паклитаксела has been investigated, and one of them (С9344) has shown increase безрецидивной and the general{common} survival rate at patients with рецептороотрицательными tumours at use паклитаксела is consecutive with a mode the EXPERT. Подробнее...

The arsenal of the antineoplastic means used for carrying out of chemotherapy of the second line is extraordinary great. To them concern паклитаксел, доцетаксел, топотекан, липосомальный доксорубицин, пероральный этопозид, винорельбин, гемцитабин, оксалиплатин, алтретамин, ифосфамид. So big list of preparations is more likely the certificate of that any of them does not allow to reach{achieve} long remissions at the majority of patients. Efficiency of them changes from 12 up to 40 % at average life expectancy of 9-12 months. Подробнее...